4 Comments

Another great post, Bruce.

The way you've presented it, variolation seems like a no-brainer. Aside from profitability (and lack thereof), are there other reasons to avoid it as an intervention? I can't think of anyone else having discussed this vis-a-vis covid.

It follows the same abysmal trend of the general failure to study. It's like panic destroyed curiosity. We still don't have a robust RCT for masking, for example. Endless money to supersize viruses, but none to study interventions.

Expand full comment

Thank you reposted

Expand full comment